FDA Rejects Teva's Specifications For Approving Generic Copaxone
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency denies Teva's citizen petition to block approval of pending ANDAs; FDA's Janet Woodcock indicates what tests might be required to show a generic has the same active ingredient as Copaxone.